NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered PT-141 from Peptide Technologies? Mail in a sample (US only) and let us test it for free.

Test my supply
62%
Finnrick rating
#18 of 33 PT-141 vendors
1 of 2 classifiable tests passed
natural 50%
methodology · Purity focus
Finnrick analysis · PT-141

Peptide Technologies' PT-141 profile is mixed because one PT-001 result showed 99.346% purity, below the 99.5% cutoff, while identity and fill passed. With only two same-day tests from one batch, the signal is narrow rather than a trend.

methodology →
vendor intelligence report
Vendor Intelligence Report: Peptide Technologies

We investigated who actually operates Peptide Technologies — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.

23 pages5 risk factors assessed13 Jun 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Semaglutide
$11.99
74%
4
2
PT-141selected
$3.50
62%
2
3
BPC-157
$5.00
48%
5
4
Tesamorelin
$5.67
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%16 Mar 2025: 22%16 Mar 2025: 21%20 Sept 2026: current 62%22%62%Mar 25Sep 26
Showing PT-141 tests only
Peptide Technologies PT-141 test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
16 Mar 2025Fail
Tested
lab nameView COA
16 Mar 2025Pass
Tested
lab nameView COA

About Peptide Technologies test results from Finnrick

Peptide Technologies is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 3 peptides and 11 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Peptide Technologies peptides in this dataset are BPC-157 (5 tests), PT-141 (2 tests) and Semaglutide (4 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 11 recent tests.

Corrections
No corrections.
Free peptide testing

Ordered PT-141 from Peptide Technologies? Mail in a sample (US only) and let us test it for free.

Test my supply